Dal-Ré Saavedra R, Gil Miguel A, Hernández-Sampelayo Matos T
Departamento Médico, SmithKline Beecham Pharmaceuticals, Madrid.
Aten Primaria. 2000 Oct 31;26(7):439-45. doi: 10.1016/s0212-6567(00)78700-2.
To describe the overall characteristics of prospective studies on vaccines in children, performed by Spanish investigators and published between 1990 and 1998.
Through a bibliographic research on MEDLINE and EMBASE, 24 prospective studies, performed in Spain, published as original papers, and with objectives directly related to the administration of vaccines to children have been identified. These studies were grouped as: clinical trials (group A), studies performed on established vaccination programmes (group B), and those that could not be included in the above mentioned groups (group C).
5, 9 and 10 studies belonged to groups A, B and C, respectively. More than 12,800 subjects participated in these studies, belonging to both normal population or specific risk groups. In 11 studies, the study population comprised newborns and infants. The vaccines under investigation were: hepatitis B (10 studies), DTPe/Pa (6), MMR (3), flu (2), Hib (1), hepatitis A (1), and meningococcus A and C (1) to address different objectives (in most of them, immunogenicity and/or reactogenicity). Nine had external financial support; 21 were performed by hospital and/or primary care investigators, and 18 in the Vasque Coutry, Madrid or Valencia. 13 publications reported obtaining informed consent, and 8 on the approval of the study protocol by an independent committee. Ten studies were published by international journals.
This study shows that most of the studies are conducted by clinicians, with vaccines targetted to newborns and infants, with no external financial support, in a small number of autonomous communities, and usually published in Spanish Journals. The submission of this type of studies to a research ethics committee is desirable, something done to a lesser extent than obtaining informed consent.
描述西班牙研究人员在1990年至1998年间开展并发表的关于儿童疫苗的前瞻性研究的总体特征。
通过对MEDLINE和EMBASE进行文献检索,确定了24项在西班牙开展的、作为原始论文发表的、目标与儿童疫苗接种直接相关的前瞻性研究。这些研究分为:临床试验(A组)、针对既定疫苗接种计划开展的研究(B组)以及无法归入上述组别的研究(C组)。
分别有5项、9项和10项研究属于A组、B组和C组。超过12800名受试者参与了这些研究,受试者来自正常人群或特定风险群体。在11项研究中,研究人群包括新生儿和婴儿。所研究的疫苗有:乙型肝炎疫苗(10项研究)、白喉破伤风无细胞百日咳/脊髓灰质炎疫苗(6项)、麻疹腮腺炎风疹疫苗(3项)、流感疫苗(2项)、b型流感嗜血杆菌疫苗(1项)、甲型肝炎疫苗(1项)以及A群和C群脑膜炎球菌疫苗(1项),以实现不同目标(大多数研究针对免疫原性和/或反应原性)。9项研究有外部资金支持;21项由医院和/或初级保健研究人员开展,18项在巴斯克地区、马德里或巴伦西亚开展。13篇出版物报告获得了知情同意,8篇报告研究方案获得独立委员会批准。10项研究发表在国际期刊上。
本研究表明,大多数研究由临床医生开展,针对新生儿和婴儿的疫苗,无外部资金支持,在少数自治区进行,且通常发表在西班牙期刊上。这类研究提交给研究伦理委员会是可取的,但在这方面做得比获得知情同意要少。